optic neuropathy semaglutide Breaking Med Last month, the European Medicines

Wisp, a virtual provider of sexual and reproductive health services, is launching a new weight care vertical to help women struggling with hormonal imbalances

Its easy to become fixated on the very small and still-debated risk of a medication while ignoring the much larger and clear risks of foregoing treatment

Variations in study design, diagnostic criteria, and population characteristics limited comparability and prevented meta-analysis

GLP-Pro targets natural GLP-1 production at the gut level with the pasteurized form of the probiotic super strain Akkermansia

Clinical studies show significant results independent of formal diet plans, though nutrition choices still matter for overall health

Een nieuwe studie, die onlangs is gepubliceerd in JAMA Network Open, suggereert dat GLP-1 (glucagon-like peptide-1) receptoragonisten, die momenteel goedgekeurd zijn voor de behandeling van diabetes en obesitas, mogelijk een bijkomend voordeel hebben: ze kunnen het risico op bepaalde met obesitas geassocieerde kankers (obesity associated cancers, OACs) verminderen